Loading company…
Tolemy Bio develops AI tools for understanding and controlling cellular systems.
Tolemy Bio Ltd is a biotechnology company developing an AI-native platform that combines biological data, computational models, and experimental workflows. Its Orbit platform helps scientists study and direct cellular systems, initially for cell therapy and biomanufacturing. The company raised €1.4 million in pre-seed funding, with participation from Norrsken Evolve, Big Sur Ventures, JME Ventures, Masia, and other investors. The funding is intended for platform development, hiring, and early customer engagement.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in